ARTICLE | Politics & Policy
FDA to invest $500M on regulatory innovation
July 7, 2017 10:24 PM UTC
On Friday, FDA released plans for investing a $500 million innovation fund authorized in the 21st Century Cures Act. The funding, to be spent from FY17-FY25, is subject to annual appropriations from Congress.
In a blog post, FDA Commissioner Scott Gottlieb positioned the agency’s plans for investing the innovation fund as steps that will both improve public health by facilitating biomedical innovation and reduce drug costs by cutting the burden of unnecessary regulation...